Physiology and pathophysiology of drug receptor mechanisms
药物受体机制的生理学和病理生理学
基本信息
- 批准号:01304028
- 负责人:
- 金额:$ 4.61万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Co-operative Research (A)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Physiological and pathophysiological roles of drug receptors in various organs were investigated in this research group and the following results and conclusions were obtained. 1) Continuous exposure of primary cultured neurons to muscarinic agonists and/or antagonists induced down- and/or up-regulation of the receptor and these changes were accompanied with those in second messenger systems coupled with the receptor. 2) The membrane stabilizing effect was essential for the protecting effect of various drugs on cardiac myopathy induced by cardiac ischemia. 3) The proliferation of vascular endotherial cells, which plays an important role in the progession of arteriosclerosis, was associated with the stimulation of alpha_1-adrenoceptor by cathecholamines. 4) The development of functional tolerance to morphine was prevented by the concomitant administrations of adrenergic blockers, k-opioid receptor agonist and calcium channel blockers. 5) Potassium channel opener selectively inhibited IP_3 -induced CA^<++> release in the heart. 6) Central dopamine D_1 receptor was operated when the excess of dopamine release was induced. 7) The function of adrenergic receptors in vascular smooth muscle showed a decrease with the progression of aging, while cholinergic receptors in this tissue were not affected significantly by aging. 8) The bata-receptors in the coronary artery were mostly beta_1 type. 9) The dilatation of cerebral arteries was mediated by the increase of cGMP caused by the activation of guanylate cyclase with NO. 10) Endothelin inhibited ganglionic transmission by ganglionic stimulation of thromboxane A_2 production as well as postganglionic activation of Ca^<++> dependent K^+channel. 11) The hypothalamus possessed both subsaince P and opioid receptors which are involved in the regulation of urinary outflow.
本课题组研究了药物受体在各器官中的生理和病理生理作用,并获得了以下结果和结论。1)原代培养的神经元连续暴露于毒蕈碱激动剂和/或拮抗剂诱导的受体的下调和/或上调,这些变化伴随着与受体偶联的第二信使系统。2)膜稳定作用是各种药物对心肌缺血所致心肌病变保护作用的基础。3)血管内皮细胞的增殖在动脉粥样硬化的发生发展中起重要作用,其增殖与胆碱能刺激α_1-肾上腺素能受体有关。4)同时给予肾上腺素能受体阻滞剂、K-阿片受体激动剂和钙通道阻滞剂可防止对吗啡的功能性耐受。5)钾通道开放剂选择性地抑制IP_3诱导的心肌CA^++释放。6)当多巴胺释放过量时,中枢多巴胺D_1受体起作用。7)血管平滑肌中肾上腺素能受体的功能随增龄而下降,而胆碱能受体的功能则不受增龄的影响。8)冠状动脉β受体以β_1型为主。9)NO激活鸟苷酸环化酶引起cGMP增加,从而引起脑动脉扩张。10)内皮素通过刺激神经节血栓素A_2的产生和节后Ca^++依赖性K^+通道的激活抑制神经节传递。11)下丘脑具有参与尿流出调节的P物质受体和阿片受体。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Yanagisawa,H.Hashioto,N.Taira: "Interaction of potassium channel openers and blockers in canine atrial muscle" Britich Journal Pharmacology. 97. 753-762 (1989)
T.Yanagisawa、H.Hashioto、N.Taira:“犬心房肌中钾通道开放剂和阻滞剂的相互作用”Briich Journal Pharmacology。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S. Ohkuma: "Alterations in receptor coupled second messenger systems at up-regulated muscarinic receptors : Analysis using primary cultured neurons" European Journal of Pharmacology. 189. 277-285 (1990)
S. Ohkuma:“毒蕈碱受体上调的受体偶联第二信使系统的改变:使用原代培养神经元进行分析”《欧洲药理学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Okamura,Y.Minami,N.Toda: "Endothelium-Dependent and -Independent Mechanisms of Action of Acetylcholine in Monkey and Dog Isolated Arteries" Pharmacology. 38. 279-288 (1989)
T.Okamura、Y.Minami、N.Toda:“乙酰胆碱在猴和狗离体动脉中的内皮依赖性和独立作用机制”药理学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Yanagisawa: "Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim,pinacidil and nicorandil" Br.J.Pharmacol.101. 157-165 (1990)
T.Yanagisawa:“克罗卡林、吡那地尔和尼可地尔产生的细胞质钙和犬冠状动脉平滑肌的松弛”Br.J.Pharmacol.101。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Okada: "An analysis of the nitrateーlike and K channel opening actions of KRN 2391 in canine coronary arterial smooth muscle" British Journal of Pharmacology. 104. 829-838 (1991)
Y.Okada:“KRN 2391 在犬冠状动脉平滑肌中的硝酸盐样和 K 通道开放作用的分析”英国药理学杂志 104. 829-838 (1991)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KURIYAMA Kinya其他文献
KURIYAMA Kinya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KURIYAMA Kinya', 18)}}的其他基金
JOINT STUDY ON STRUCTURE AND FUNCTION OF GABA_B RECEPTOR
GABA_B受体结构与功能的联合研究
- 批准号:
06044193 - 财政年份:1994
- 资助金额:
$ 4.61万 - 项目类别:
Grant-in-Aid for international Scientific Research
STUDIES OF STRUCTURE AND FUNCTION ON CEREBRAL GABA_B RECEPTOR
脑GABA_B受体结构与功能的研究
- 批准号:
05454152 - 财政年份:1993
- 资助金额:
$ 4.61万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Immunohistochemical analysis of neuronal networks in brain using antibody for neurotransmitter receptors
使用神经递质受体抗体对大脑神经元网络进行免疫组织化学分析
- 批准号:
02557011 - 财政年份:1990
- 资助金额:
$ 4.61万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Purification of -aminobutyric acid (GABA) receptor and formation of monoclonal antibody against the purified receptor.
γ-氨基丁酸(GABA)受体的纯化和针对纯化受体的单克隆抗体的形成。
- 批准号:
59480120 - 财政年份:1984
- 资助金额:
$ 4.61万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
G PROTEIN NULL MUTATION AND CARDIAC RECEPTOR SIGNALING
G 蛋白无效突变和心脏受体信号传导
- 批准号:
2713926 - 财政年份:1998
- 资助金额:
$ 4.61万 - 项目类别:
G PROTEIN NULL MUTATION AND CARDIAC RECEPTOR SIGNALING
G 蛋白无效突变和心脏受体信号传导
- 批准号:
6017188 - 财政年份:1998
- 资助金额:
$ 4.61万 - 项目类别:
G PROTEIN NULL MUTATION AND CARDIAC RECEPTOR SIGNALING
G 蛋白无效突变和心脏受体信号传导
- 批准号:
2707630 - 财政年份:1998
- 资助金额:
$ 4.61万 - 项目类别:
G PROTEIN NULL MUTATION AND CARDIAC RECEPTOR SIGNALING
G 蛋白无效突变和心脏受体信号传导
- 批准号:
6182476 - 财政年份:1998
- 资助金额:
$ 4.61万 - 项目类别:
G PROTEIN NULL MUTATION AND CARDIAC RECEPTOR SIGNALING
G 蛋白无效突变和心脏受体信号传导
- 批准号:
2211667 - 财政年份:1996
- 资助金额:
$ 4.61万 - 项目类别: